Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study
- PMID: 19200383
- PMCID: PMC2649113
- DOI: 10.1186/1471-2369-10-3
Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study
Abstract
Background: The use of peritoneal dialysis (PD) has declined in the United States over the past decade and technique failure is also reportedly higher in PD compared to hemodialysis (HD), but there are little data in the United States addressing the factors and outcomes associated with switching modalities from PD to HD.
Methods: In a prospective cohort study of 262 PD patients enrolled from 28 peritoneal dialysis clinics in 13 U.S. states, we examined potential predictors of switching from PD to HD (including demographics, clinical factors, and laboratory values) and the association of switching with mortality. Cox proportional hazards regression was used to assess relative hazards (RH) of switching and of mortality in PD patients who switched to HD.
Results: Among 262 PD patients, 24.8% switched to HD; with more than 70% switching within the first 2 years. Infectious peritonitis was the leading cause of switching. Patients of black race and with higher body mass index were significantly more likely to switch from PD to HD, RH (95% CI) of 5.01 (1.15-21.8) for black versus white and 1.09 (1.03-1.16) per 1 kg/m2 increase in BMI, respectively. There was no difference in survival between switchers and non-switchers, RH (95% CI) of 0.89 (0.41-1.93).
Conclusion: Switching from PD to HD occurs early and the rate is high, threatening long-term viability of PD programs. Several patient characteristics were associated with the risk of switching. However, there was no survival difference between switchers and non-switchers, reassuring providers and patients that PD technique failure is not necessarily associated with poor prognosis.
Figures
Similar articles
-
Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients?Nefrologia. 2012 May 14;32(3):335-42. doi: 10.3265/Nefrologia.pre2012.Jan.11143. Epub 2012 Apr 17. Nefrologia. 2012. PMID: 22508142
-
[Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].Nefrologia. 2011;31(2):174-84. doi: 10.3265/Nefrologia.pre2011.Jan.10743. Nefrologia. 2011. PMID: 21461011 Spanish.
-
Peritoneal dialysis and kidney transplant. A two-way ticket in an integrated renal replacement therapy model.Nefrologia. 2011;31(4):441-8. doi: 10.3265/Nefrologia.pre2011.May.10898. Nefrologia. 2011. PMID: 21738247 English, Spanish.
-
Outcomes after transfer from hemodialysis to peritoneal dialysis vs peritoneal dialysis as initial therapy: A systematic review and meta-analysis.Semin Dial. 2020 Jul;33(4):299-308. doi: 10.1111/sdi.12896. Epub 2020 Jun 29. Semin Dial. 2020. PMID: 32596853 Review.
-
New-Onset Diabetes Mellitus in Peritoneal Dialysis and Hemodialysis Patients: Frequency, Risk Factors, and Prognosis-A Review.Ther Apher Dial. 2019 Dec;23(6):497-506. doi: 10.1111/1744-9987.12800. Epub 2019 Apr 23. Ther Apher Dial. 2019. PMID: 30854792 Free PMC article. Review.
Cited by
-
Aryl Hydrocarbon Receptor Pathway Augments Peritoneal Fibrosis in a Murine CKD Model Exposed to Peritoneal Dialysate.Kidney360. 2024 Sep 1;5(9):1238-1250. doi: 10.34067/KID.0000000000000516. Epub 2024 Sep 5. Kidney360. 2024. PMID: 39235862 Free PMC article.
-
The Controversies of Coronary Artery Disease in End-Stage Kidney Disease Patients: A Narrative Review.Rev Cardiovasc Med. 2023 Jun 25;24(6):181. doi: 10.31083/j.rcm2406181. eCollection 2023 Jun. Rev Cardiovasc Med. 2023. PMID: 39077541 Free PMC article. Review.
-
Retroperitoneal leakage as an important cause of acquired ultrafiltration decline in peritoneal dialysis: clinical characteristics and related risk factors.J Nephrol. 2024 Sep;37(7):1997-2005. doi: 10.1007/s40620-024-02009-3. Epub 2024 Jul 13. J Nephrol. 2024. PMID: 38997573
-
Diagnostic Accuracy of MMP-8 and IL-6-Based Point-of-Care Testing to Detect Peritoneal Dialysis-Related Peritonitis: A Single-Center Experience.Diagnostics (Basel). 2024 May 27;14(11):1113. doi: 10.3390/diagnostics14111113. Diagnostics (Basel). 2024. PMID: 38893639 Free PMC article.
-
Integrated home dialysis model: facilitating home-to-home transition.Clin Kidney J. 2024 Jun 5;17(Suppl 1):i21-i33. doi: 10.1093/ckj/sfae079. eCollection 2024 May. Clin Kidney J. 2024. PMID: 38846416 Free PMC article.
References
-
- Wu AW, Fink NE, Marsh-Manzi JV, Meyer KB, Finkelstein FO, Chapman MM, Powe NR. Changes in Quality of Life during Hemodialysis and Peritoneal Dialysis Treatment: Generic and Disease Specific Measures. J Am Soc Nephrol. 2004;15:743–753. doi: 10.1097/01.ASN.0000113315.81448.CA. - DOI - PubMed
-
- U.S. Renal Data System, USRDS 2007 Annual Data Report. Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2007.
-
- Gokal R, King J, Bogle S, Marsh F, Oliver D, Jakubowski C, Hunt L, Baillod R, Ogg C, Ward M, Wilkinson R. Outcome in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of a prospective multicentre study. The Lancet. 1987;330:1105–1109. doi: 10.1016/S0140-6736(87)91544-3. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
